Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome

Figure 3

Expression of miR-15a, miR-16-1, and miR-193a in sera from patients with NS. Relative expression levels of miR-15a (a) in patients with NS (nephrotic syndrome) and healthy subjects (HS) and (b) in patients with steroid-sensitive NS (SSNS) and steroid-resistant NS (SRNS). miR-16-1 (c) in patients with NS and HS and (d) in patients with SSNS and SRNS and miR-193a (e) in patients with NS and HS and (f) in patients with SSNS and SRNS., , and .

(a)

(b)

(c)

(d)

(e)

(f)